Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis) | Zendy

Colin P. Derdeyn | Zendy; David Fiorella | Zendy; Michael Lynn | Zendy; Tanya N. Turan | Zendy; George Cotsonis | Zendy; Bethany F Lane | Zendy; Jean Montgomery | Zendy; L. Scott Janis | Zendy; Marc I. Chimowitz | Zendy

Open Access

Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis)

Author(s) -

Colin P. Derdeyn,

David Fiorella,

Michael Lynn,

Tanya N. Turan,

George Cotsonis,

Bethany F Lane,

Jean Montgomery,

L. Scott Janis,

Marc I. Chimowitz

Publication year - 2017

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.116.014537

Subject(s) - medicine , restenosis , stroke (engine) , angioplasty , cardiology , stenosis , stent , cerebral infarction , infarction , clinical endpoint , surgery , myocardial infarction , radiology , ischemia , randomized controlled trial , mechanical engineering , engineering

The purpose of this study was to investigate the frequency of symptomatic in-stent restenosis (ISR) and its contribution to nonprocedural symptomatic infarction in the SAMMPRIS trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research